Featured Research

from universities, journals, and other organizations

Opthalmologists Discover Relationship Between Eye Condition And Attention Deficit Hyperactivity Disorder

Date:
April 17, 2000
Source:
University Of California, San Diego
Summary:
UCSD Shiley Eye Center ophthalmologists and researchers have uncovered a relationship between an eye disease characterized by an inability to focus on a target and attention deficit hyperactivity disorder (ADHD).

UCSD Shiley Eye Center ophthalmologists and researchers have uncovered a relationship between an eye disease characterized by an inability to focus on a target and attention deficit hyperactivity disorder (ADHD).

“We showed that children with the disorder, convergence insufficiency are three times as likely to be diagnosed with ADHD than children without the disorder,” according to David B. Granet, M.D., a UCSD School of Medicine associate professor of ophthalmology and pediatrics and director of the UCSD Ratner Children’s Eye Center. “This is the first time such a relationship has been identified between these two disorders.”

Convergence insufficiency, a disorder that affects less than five percent of children, is a physical eye problem that makes it hard to keep both eyes pointed and focused at a near target, making it difficult to maintain concentration when reading. ADHD is considered to be one of the most common psychiatric disorders in children.

When reviewing 266 charts of patients with convergence insufficiency, Dr. Granet and his colleagues found that 26 patients (9.8%) were diagnosed with ADHD sometime in their life. Of those, 20 (76.9%) were on medication for ADHD when they were diagnosed with convergence insufficiency. “When we turned it around and looked at the ADHD population we found an almost 16 percent incidence of convergence insufficiency, or again more than three times what you’d expect.”

“The significance of this relationship is intriguing,” Dr. Granet said. “We don’t know if convergence insufficiency makes ADHD worse or if convergence insufficiency is misdiagnosed as ADHD. What we do know is that more research must be done on this subject and that patients diagnosed with ADHD should also be evaluated for convergence insufficiency and treated accordingly. Further work may aid in understanding both disorders.”

Dr. Granet added that convergence insufficiency is one of the very few ocular conditions that respond to eye exercises (orthoptics) which can be done at home.


Story Source:

The above story is based on materials provided by University Of California, San Diego. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Diego. "Opthalmologists Discover Relationship Between Eye Condition And Attention Deficit Hyperactivity Disorder." ScienceDaily. ScienceDaily, 17 April 2000. <www.sciencedaily.com/releases/2000/04/000417095552.htm>.
University Of California, San Diego. (2000, April 17). Opthalmologists Discover Relationship Between Eye Condition And Attention Deficit Hyperactivity Disorder. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/04/000417095552.htm
University Of California, San Diego. "Opthalmologists Discover Relationship Between Eye Condition And Attention Deficit Hyperactivity Disorder." ScienceDaily. www.sciencedaily.com/releases/2000/04/000417095552.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins